Aims
The Journal of Inflammation Biology and Medicine publishes peer-reviewed research addressing the biological mechanisms, clinical manifestations, diagnosis, treatment, and translational aspects of inflammation and inflammation-associated diseases.
Scope
The journal welcomes basic, experimental, clinical, and translational studies that advance understanding of inflammatory processes and their implications for human health and disease.
Areas of interest include:
- Inflammation
- Acute and chronic inflammation
- Innate and adaptive immune responses
- Biologics and targeted therapies
- Cytokines, chemokines, and inflammatory mediators
- Inflammatory signaling pathways
- Immunometabolism and metabolic inflammation
- Autoimmune and immune-mediated diseases
- Neuroinflammation and inflammation-associated neurological disorders
- Cardiovascular inflammation
- Gastrointestinal and hepatic inflammation
- Respiratory and pulmonary inflammation
- Sepsis and systemic inflammation
- Musculoskeletal and rheumatic inflammation
- Skin inflammation
- Renal and hepatic inflammation
- Metabolic and obesity-associated inflammation
- Cancer-associated inflammation and the tumor microenvironment
- Dermatological inflammation
- Sepsis and systemic inflammation
- Microbiome–immune interactions
- Inflammation biomarkers
- Molecular and cellular biomarkers
- Inflammation-associated biomarkers and diagnostic approaches
- Molecular and cellular mechanisms of inflammation
- Anti-inflammatory drugs and pharmacological interventions
- Immunomodulatory therapies
- Renal and urological inflammation
- Translational and clinical inflammation research
- Experimental models of inflammation
- Inflammation-related diagnosis and disease management
- Therapeutic efficacy, treatment response, and clinical outcomes
- Inflammaging and age-associated inflammatory processes
The journal welcomes clinically relevant case reports and case series offering diagnostic, therapeutic, pathological, or mechanistic insights into inflammatory and immune-mediated conditions. Research using emerging technologies, computational methods, artificial intelligence, and data-driven approaches is considered when directly relevant to the study, diagnosis, prediction, or management of inflammatory disease.
Submissions are welcomed from relevant clinical, academic, biomedical, pharmaceutical, and research settings. Manuscripts are evaluated based on scientific relevance, methodological rigor, ethical standards, and contribution to the field, without restriction to a specific organ system, disease category, model, or therapeutic approach.
Trusted by Researchers
Experiences from authors who have published with SCIVOLVE.